COMPARISON OF A NOVEL, LABEL-FREE, AND REAL-TIME CELL BASED SYSTEM (XCELLIGENCE) WITH A CONVENTIONAL VIABILITY ASSAY (XTT) TO DETERMINE THE ANTI-PROLIFERATIVE EFFECT OF AT-101 IN HUMAN BREAST CANCER CELLS

Simple item page
dc.contributor.authorKaraca, B
dc.contributor.authorAtmaca, H
dc.contributor.authorAsli, K
dc.contributor.authorBozkurt, E
dc.contributor.authorCakar, B
dc.contributor.authorSurmeli, ZG
dc.contributor.authorGursoy, P
dc.contributor.authorKarabulut, B
dc.contributor.authorUzunoglu, S
dc.contributor.authorSezgin, C
dc.date.accessioned2025-04-10T10:30:51Z
dc.date.available2025-04-10T10:30:51Z
dc.identifier.issn0923-7534
dc.identifier.urihttp://hdl.handle.net/20.500.14701/37416
dc.language.isoEnglish
dc.titleCOMPARISON OF A NOVEL, LABEL-FREE, AND REAL-TIME CELL BASED SYSTEM (XCELLIGENCE) WITH A CONVENTIONAL VIABILITY ASSAY (XTT) TO DETERMINE THE ANTI-PROLIFERATIVE EFFECT OF AT-101 IN HUMAN BREAST CANCER CELLS
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu